Pacer Advisors’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-64
| Closed | – | – | 2378 |
|
|
2025
Q4 | $0 | Buy |
+64
| New | – | ﹤0.01% | 3876 |
|
|
2022
Q4 | – | Sell |
-38,924
| Closed | -$9.56M | – | 3376 |
|
|
2022
Q3 | $9.56M | Buy |
38,924
+36,511
| +1,513% | +$9.86M | 0.07% | 247 |
|
|
2022
Q2 | $597K | Sell |
2,413
-3,854
| -61% | -$1.04M | ﹤0.01% | 648 |
|
|
2022
Q1 | $2.08M | Buy |
6,267
+3,323
| +113% | +$1.02M | 0.02% | 614 |
|
|
2021
Q4 | $1.06M | Sell |
2,944
-1,335
| -31% | -$451K | 0.01% | 1165 |
|
|
2021
Q3 | $1.39M | Sell |
4,279
-78
| -2% | -$26.4K | 0.02% | 764 |
|
|
2021
Q2 | $1.36M | Buy |
4,357
+1,874
| +75% | +$575K | 0.02% | 736 |
|
|
2021
Q1 | $791K | Sell |
2,483
-450
| -15% | -$144K | 0.01% | 874 |
|
|
2020
Q4 | $951K | Sell |
2,933
-2,188
| -43% | -$605K | 0.02% | 724 |
|
|
2020
Q3 | $1.42M | Sell |
5,121
-738
| -13% | -$213K | 0.03% | 557 |
|
|
2020
Q2 | $1.42M | Buy |
+5,859
| New | +$1.18M | 0.03% | 470 |
|
|
2020
Q1 | – | Sell |
-4,855
| Closed | -$828K | – | 1189 |
|
|
2019
Q4 | $828K | Sell |
4,855
-1,263
| -21% | -$234K | 0.04% | 619 |
|
|
2019
Q3 | $1.09M | Buy |
6,118
+1,236
| +25% | +$267K | 0.02% | 789 |
|
|
2019
Q2 | $1.27M | Buy |
4,882
+830
| +20% | +$220K | 0.03% | 716 |
|
|
2019
Q1 | $1.16M | Buy |
+4,052
| New | +$1.35M | 0.03% | 420 |
|
|
2018
Q4 | – | Sell |
-2,328
| Closed | -$1.05M | – | 1109 |
|
|
2018
Q3 | $1.05M | Buy |
2,328
+354
| +18% | +$140K | 0.04% | 634 |
|
|
2018
Q2 | $807K | Sell |
1,974
-9,512
| -83% | -$3.45M | 0.04% | 734 |
|
|
2018
Q1 | $3.34M | Buy |
11,486
+1,360
| +13% | +$345K | 0.18% | 90 |
|
|
2017
Q4 | $1.9M | Buy |
10,126
+3,036
| +43% | +$567K | 0.13% | 161 |
|
|
2017
Q3 | $1.2M | Buy |
7,090
+1,038
| +17% | +$157K | 0.11% | 226 |
|
|
2017
Q2 | $867K | Buy |
6,052
+613
| +11% | +$82.4K | 0.09% | 308 |
|
|
2017
Q1 | $681K | Buy |
5,439
+862
| +19% | +$99.9K | 0.08% | 339 |
|
|
2016
Q4 | $516K | Buy |
4,577
+248
| +6% | +$28.7K | 0.07% | 381 |
|
|
2016
Q3 | $557K | Buy |
4,329
+1,244
| +40% | +$149K | 0.08% | 321 |
|
|
2016
Q2 | $337K | Buy |
+3,085
| New | +$307K | 0.05% | 518 |
|
Other funds holding ABMD
Pacer Advisors's ABMD Position: Q1 2026 in Review
Pacer Advisors sold out of Abiomed Inc (ABMD) in Q1 2026, closing a stake of 64 shares.
Pacer Advisors first reported a position in ABMD in Q2 2016 and held it in 25 quarters. The position peaked at $9.56M in Q3 2022. 1 fund tracked by Wall St. Rank holds ABMD as of Q1 2026.
- Pacer Advisors reported no remaining Abiomed Inc position as of Q1 2026 after selling out during the quarter.
- Pacer Advisors sold 64 Abiomed Inc shares in Q1 2026.
- Pacer Advisors first reported a position in Abiomed Inc in Q2 2016 and held it in 25 quarters.
- Pacer Advisors's Abiomed Inc position peaked at $9.56M in Q3 2022.
- 1 fund tracked by Wall St. Rank held Abiomed Inc as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.